PUBLIC CONTRACT · 2025
AD/2724/2025Aquisição de Eculizumab 300 mg Sol inj Fr 30 ml IV, para a ULSTMAD, EPE (A.U.E. 202502385_BCKMR)
- Contract value
- €154,087.50
- Signed on
- 20 September 2025
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 13303343PUBLISHED DESCRIPTION
AD 2724/2025 Aquisição de Eculizumab 300 mg Sol inj Fr 30 ml IV, para a ULSTMAD, EPE (A.U.E. 202502385_BCKMR)
Parties involved
- Place of performance
- Portugal, Vila Real, Vila Real
- NUTS region
- PT11D - Douro
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- ALEXION PHARMA SPAIN S L - SUCURSAL PORTUGAL · Tax ID 980553768
Values and timeline
- Contract price
- €154,087.50
- Procedure base price
- €154,087.50
- Total effective price
- Not reported on Portal BASE
- Publication date
- 11 February 2026
- Award date
- 16 July 2025
- Signing date
- 20 September 2025
- Performance period
- 180 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea ii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7950943
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.